All
AmideBio, LLC
AmideBio discovers and develops novel peptides for the treatment of metabolic diseases. In addition, AmideBio leverages its proprietary BioPure™ peptide manufacturing technology to supply ultrapure peptides for research purposes.
Industry: Therapeutics
Funding Stage: Series A Round
Arpeggio Biosciences
Arpeggio makes better drugs by discovering mechanism of action sooner.
Industry: Genomics, Therapeutics
Funding Stage: Series A Round
Artimus Robotics, Inc.
Artimus Robotics is changing the way the world moves by enabling life like motion solutions in robotics and automation.
Industry: Robotics, Hardware & Instrumentation
Funding Stage: Series A Round
Aspero Medical, Inc.
Aspero Medical focuses on improving gastrointestinal endoscopy for the patient and physician. Our technology enhances device performance, saving time and money, while improving patient outcomes.
Industry: Medical Devices
Funding Stage: Series A Round
Ayar Labs, Inc.
Ayar Labs solves the I/O bandwidth and power bottlenecks in computing systems by moving data using light.
Industry: AI & Big Data, Optics
Funding Stage: Series B Round or beyond
Bactria Pharmaceuticals, LLC
Bactria's mission is combating bacterial antibiotic resistance. The company's initial focus is on the discovery and development of small molecule therapeutics that reverse existing and emergent resistance to antibiotics in the most problematic and severe bacterial Healthcare Associated Infections (HAIs).*
Industry: Therapeutics
Funding Stage: Seed Round
BCell Solutions, Inc.
BCell Solutioions is commercializing proprietary immunotherapies computationally designed to treat newly discovered causes of unwanted inflammation.
Industry: Therapeutics
Funding Stage: Seed Round
Big Blue Technologies
Big Blue Technologies aims to demonstrate the world‘s most energy and material efficient process for primary magnesium metal production to proliferate light-weight components in vehicles, aircraft and portable electronics.
Industry: Sustainability
Funding Stage: Seed Round
BioLoomics
BioLoomics utilizes sythetic biology and cell imaging to discover and develop protein drugs.
Industry: Therapeutics
Funding Stage: Series A Round
ColdQuanta, Inc.
ColdQuanta is a quantum atomic company developing quantum computing, sensing and signal processing hardware.
Industry: Quantum, Hardware & Instrumentation
Funding Stage: Series B Round or beyond
Darwin Biosciences
Darwin Biosciences is developing saliva-based diagnostics for the early detection of infectious diseases that will change the way the world identifies and manages outbreaks.
Industry: Diagnostics
Funding Stage: Seed Round, Series A Round
Double Helix Optics
Double Helix Optics designs and manufactures sensors and imaging instruments for precision 3D imaging for use in scientific R&D, drug development, industrial inspection and machine vision utilizing our patented phase mask technology and optimization imaging algorithms.
Industry: Optics, Hardware & Instrumentation
Funding Stage: Series A Round
HiveTech Solutions, LLC
HiveTech's modular, climate-controlled apiary system dramatically improves honeybee survival rates.
Industry: Sustainability, AI & Big Data
Funding Stage: Seed Round
Inscripta
Inscripta is a digital genome engineering company providing tools based on CRISPR gene editing technology.
Industry: Genomics, Hardware and Instrumentation
Funding Stage: Series B Round or beyond
LongPath Technologies, Inc.
LongPath Technologies continuously monitors methane for oil & gas infrastructure.
Industry: Optics, Sustainability
Funding Stage: Seed Round
LumenAstra
LumenAstra™ is commercializing a patent for a non-invasive, wearable core body temperature sensor.
Industry: Medical Devices
Funding Stage: Seed Round
Mallinda, Inc.
Mallinda is an industry-leading developer of malleable thermoset and composite technologies that enable materials’ moldability, rehealability and recyclability.
Industry: Advanced Materials, Sustainability
Funding Stage: Series B Round or beyond
Meati Foods
Meati Foods is focused on using proprietary, clean technologies to provide nutritious, fungi-based protein that everyone can enjoy and feel good about eating every day.
Industry: Sustainability
Funding Stage: Series B and beyond
Mycobacteria Therapeutics Corporation
Mycobacteria Therapeutics is innovating development of novel strains of mycobacteria as nutritional supplements and pharmaceuticals.
Industry: Therapeutics
Funding Stage: Seed Round
Myogen
Myogen developed a series of FDA approved medicines treating cardiovascular disease. The company was acquired by Gilead for $2.6 billion.
Industry: Therapeutics
Funding Stage: Exit
Nanoly Bioscience, Inc.
Nanoly Bioscience has developed a low cost polymer that stabilizes temperature-sensitive molecules so they don't need refrigeration and can concentrate molecules so that more can be injected at once without loss of activity.
Industry: Therapeutics
Funding Stage: Series A Round
New Iridium, Inc.
New Iridum's patent-pending next-gen photocatalysis platform provides unprecedented efficiencies in pharma and chemical manufacturing.
Industry: Therapeutics
Funding Stage: Series A Round
Nucleic Designs
Nucleic Designs are commercializing a proprietary method of gene assembly that uses uniquely modified DNA oligonucleotides.
Industry: Genomics
Funding Stage: Seed Round
OnKure, Inc.
OnKure discovers and developes next generation Histone Deacetylase (HDAC) inhibitors for the treatment of various cancers and neuropathies.
Industry: Therapeutics
Funding Stage: Series B Round or beyond
Orbital Micro Systems
Orbital Micro Systems is empowering humanity by managing environmental risk with real-time global weather intelligence.
Industry: Aerospace, AI & Big Data
Funding Stage: Series A Round
OTORO Energy, LLC
OTORO Energy provides a proprietary flow battery technology for grid-scale stationary energy storage.
Industry: Hardware & Instrumentation, Sustainability
Funding Stage: Seed Round
Point Designs
Point Designs develops innovative and robust prosthetic devices for people with partial hand amputation.
Industry: Medical Devices
Funding Stage: Seed Round
Respirogen, Inc.
Respirogen™ Micro-Oxygen (RMO) technology provides systemic oxygen delivery to the body without using the lungs, treating systemic hypoxia in lung injury COVID and ARDS patients by creating novel breakthrough therapy.
Industry: Therapeutics
Funding Stage: Seed Round
Rigid Biotech
RIGID Enzyme Immobilization reduces the time to integrate engineered enzymes within pharmaceutical manufacturing processes, reducing cost and environmental impact while increasing the search space for candidate compounds.
Industry: Advanced Materials, Sustainability
Funding Stage: Seed Round
Robotic Materials, Inc.
Robotic Materials increases manufacturing efficiency and throughput using robotics and AI.
Industry: AI & Big Data
Funding Stage: Seed Round
Sachi Bioworks, Inc.
Sachi Bioworks is a high-precision, accelerated, cloning-free gene targeting and SARS-CoV2 therapeutics.
Industry: Therapeutics
Funding Stage: Seed Round
Sionic Energy
Sionic Energy unlocks the performance of low cost silicon for the next generation Li-ion batteries.
Industry: Advanced Materials, Hardware & Instrumentation
Funding Stage: Seed Round
Sirna
Sirna pioneered platform RNA interference technology and was acquired by Merck for $1.1 billion.
Industry: Therapeutics, Genomics
Funding Stage: Exit
socialcontext.ai
socialcontext.ai provides an AI-powered brand safety floor that protects and enables the monetization of diversity, equality and inclusion news and social media content.
Industry: AI & Big Data
Funding Stage: Seed Round
Solid Power
Solid Power is an industry-leading producer of all-solid-state rechargeable batteries for electric vehicles and mobile power markets. Solid Power went public in 2021 via Special Purpose Acquisition Company.
Industry: Sustainability
Funding Stage: Exit
SomaLogic
SomaLogic seeks to improve the well-being and quality of life of every individual by transforming how diseases were detected and diagnosed. Somalogic went public in 2021 via Special Purpose Acquisition Company.
Industry: Genomics, Diagnostics
Funding Stage: Exit
Soya Biosystems, Inc.
Soya Biosystems is developing novel methods for the production of cannabinoids and other small molecules.
Industry: Therapeutics, Chemicals
Funding Stage: Seed Round
Stateless
Stateless' software platform enables enterprises and service providers (cloud MSP, colocation and network providers) to easily define and build a portfolio of elegant multi-hybrid cloud connectivity solutions.
Industry: Information Technology, Security
Funding Stage: Series B Round or beyond
Think Bioscience
Think Bioscience programs microbial systems to discover, build, and evolve small-molecule drugs.
Industry: Therapeutics, Genomics
Funding Stage: Seed Round
TissueForm
TissueForm is developing and producing tissue-based, bio-inspired and regenerative biomaterials for regenerative medicine and 3D-bioprinting applications.
Funding Stage: Seed Round
Tusaar Corp.
Tusaar Corp. transformed generic coconut carbon from a basic water treatment media to one for criticial appliications like removing lead, mercury, uranium and other toxic metals from water and the environment.
Industry: Advanced Materials, Sustainability
Funding Stage: Series B Round or beyond
Tynt Technology
Tynt Technology make inexpensive windows with adjustable tinting that prevent glare while maintaining views and save energy.
Industry: Sustainability, Advanced Materials
Funding Stage: Seed Round
VitriVax, Inc.
VitriVax, Inc. is a biotechnology company working to eliminate barriers to global vaccination, and has developed a novel stabilization and delivery platform for vaccines and therapeutics, ALTA™.
Industry: Vaccines
Funding Stage: Series A Round
Vitro3D
Vitro3D is optimizing the drug development pipeline by creating a spatially-controlled 3D printed platform that mimics the living tissue environment, allowing for the detection of viable drugs earlier in the drug screening process.
Industry: Advanced Materials, Hardware & Instrumentation
Funding Stage: Seed Round
Xalud Therapeutics
Xalud Therapeutics is developing a non-viral gene therapy targeting immune modulation, harnessing the power of interleukin-10.
Industry: Therapeutics
Funding Stage: Series B Round or beyond